GNLX
Price
$4.20
Change
-$0.01 (-0.24%)
Updated
Sep 26 closing price
Capitalization
158.65M
46 days until earnings call
RXRX
Price
$4.72
Change
+$0.09 (+1.94%)
Updated
Sep 26 closing price
Capitalization
2.06B
39 days until earnings call
Interact to see
Advertisement

GNLX vs RXRX

Header iconGNLX vs RXRX Comparison
Open Charts GNLX vs RXRXBanner chart's image
Genelux
Price$4.20
Change-$0.01 (-0.24%)
Volume$26.72K
Capitalization158.65M
Recursion Pharmaceuticals
Price$4.72
Change+$0.09 (+1.94%)
Volume$39.34M
Capitalization2.06B
GNLX vs RXRX Comparison Chart in %
Loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNLX vs. RXRX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNLX is a Hold and RXRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (GNLX: $4.19 vs. RXRX: $4.72)
Brand notoriety: GNLX and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNLX: 11% vs. RXRX: 134%
Market capitalization -- GNLX: $159.03M vs. RXRX: $2.06B
GNLX [@Biotechnology] is valued at $159.03M. RXRX’s [@Biotechnology] market capitalization is $2.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNLX’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • GNLX’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, RXRX is a better buy in the long-term than GNLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNLX’s TA Score shows that 5 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • GNLX’s TA Score: 5 bullish, 4 bearish.
  • RXRX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both GNLX and RXRX are a good buy in the short-term.

Price Growth

GNLX (@Biotechnology) experienced а +0.72% price change this week, while RXRX (@Biotechnology) price change was -3.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

GNLX is expected to report earnings on Nov 12, 2025.

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.06B) has a higher market cap than GNLX($159M). GNLX YTD gains are higher at: 77.966 vs. RXRX (-30.178). GNLX has higher annual earnings (EBITDA): -29.74M vs. RXRX (-583.64M). RXRX has more cash in the bank: 525M vs. GNLX (28M). GNLX has less debt than RXRX: GNLX (1.71M) vs RXRX (88.1M). RXRX has higher revenues than GNLX: RXRX (64.5M) vs GNLX (0).
GNLXRXRXGNLX / RXRX
Capitalization159M2.06B8%
EBITDA-29.74M-583.64M5%
Gain YTD77.966-30.178-258%
P/E RatioN/AN/A-
Revenue064.5M-
Total Cash28M525M5%
Total Debt1.71M88.1M2%
TECHNICAL ANALYSIS
Technical Analysis
GNLXRXRX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 18 days ago
85%
Declines
ODDS (%)
Bearish Trend 29 days ago
88%
Bearish Trend 12 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TEVJF20.01N/A
N/A
Teva Pharmaceutical Industries Ltd.
ENGGF16.81N/A
N/A
Enagas S.A.
JNNDF0.18N/A
N/A
Japan Display, Inc.
PVBK10.59-0.01
-0.09%
Pacific Valley Bancorp
SNBH0.03N/A
-11.47%
Sentient Brands Holdings Inc.

GNLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNLX has been loosely correlated with SYRE. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if GNLX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNLX
1D Price
Change %
GNLX100%
-0.24%
SYRE - GNLX
34%
Loosely correlated
+4.04%
RXRX - GNLX
32%
Poorly correlated
+1.94%
XNCR - GNLX
32%
Poorly correlated
+12.00%
CRSP - GNLX
32%
Poorly correlated
+2.24%
BEAM - GNLX
31%
Poorly correlated
-0.52%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
+1.94%
CRSP - RXRX
68%
Closely correlated
+2.24%
ABSI - RXRX
63%
Loosely correlated
+3.02%
BEAM - RXRX
61%
Loosely correlated
-0.52%
ABCL - RXRX
58%
Loosely correlated
+1.94%
NTLA - RXRX
54%
Loosely correlated
-1.81%
More